Sahar Barjesteh van Waalwijk van Doorn-Khosrovani

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Sahar Barjesteh van Waalwijk van Doorn-Khosrovani

Oct 30, 2024, 12:41 | Insight

Sahar Barjesteh van Waalwijk van Doorn-Khosrovani: Debates on weight-based dosing of pembrolizumab

Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Podcast Host of De Bruggenbouwers, shared on LinkedIn: “The…

Oct 23, 2024, 14:01 | Insight

Comprehensive assessment of the regulatory landscape of PD-1 and PD-L1 inhibitors

Miguel Bronchud, Co-Founder and Advisory Board at Regenerative Medicine Solutions, shared a post on LinkedIn: "Impossible…

All: 2 Posts: 1 - 100

'

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology

'

Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025

'

USA vs Europe: Who Does Cancer Screening Better?

'

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

'

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023